These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 18679062

  • 1. Changes in gene expression of gastric mucosa during therapeutic acid inhibition.
    Nørsett KG, Laegreid A, Kusnierczyk W, Langaas M, Ylving S, Fossmark R, Myhre S, Falkmer S, Waldum HL, Sandvik AK.
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):613-23. PubMed ID: 18679062
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial.
    Fiocca R, Mastracci L, Attwood SE, Ell C, Galmiche JP, Hatlebakk J, Bärthel A, Långström G, Lind T, Lundell L, LOTUS trial collaborators.
    Aliment Pharmacol Ther; 2012 Nov; 36(10):959-71. PubMed ID: 22998687
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of 6-12 months of esomeprazole treatment on the gastric mucosa.
    Genta RM, Rindi G, Fiocca R, Magner DJ, D'Amico D, Levine DS.
    Am J Gastroenterol; 2003 Jun; 98(6):1257-65. PubMed ID: 12818266
    [Abstract] [Full Text] [Related]

  • 10. Morphological changes of the human gastric mucosa under long-term proton pump inhibitor therapy and their clinical relevance.
    Lamberts R.
    Microsc Res Tech; 2000 Mar 15; 48(6):357-66. PubMed ID: 10738317
    [Abstract] [Full Text] [Related]

  • 11. Esomeprazole induces upper gastrointestinal tract transmucosal permeability increase.
    Mullin JM, Valenzano MC, Whitby M, Lurie D, Schmidt JD, Jain V, Tully O, Kearney K, Lazowick D, Mercogliano G, Thornton JJ.
    Aliment Pharmacol Ther; 2008 Dec 01; 28(11-12):1317-25. PubMed ID: 18684245
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Relationship between symptom response and esophageal pH level on standard dose of esomeprazole treatment for gastroesophageal reflux disease.
    Peng S, Xiong LS, Xiao YL, Wang AJ, Lin JK, Hu PJ, Chen MH.
    Chin Med J (Engl); 2010 Aug 05; 123(15):2012-7. PubMed ID: 20819534
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of three different dosages of esomeprazole in the long-term management of reflux disease: a prospective, randomized study, using the wireless Bravo pH system.
    Vasiliadis KV, Viazis N, Vlachogiannakos J, Sgouros SN, Stefanidis G, Archimandritis A, Karamanolis DG.
    Am J Gastroenterol; 2010 Feb 05; 105(2):308-13. PubMed ID: 19809412
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.
    Park W, Hicks DM, Khandwala F, Richter JE, Abelson TI, Milstein C, Vaezi MF.
    Laryngoscope; 2005 Jul 05; 115(7):1230-8. PubMed ID: 15995512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.